Actinium Pharmaceuticals Inc. (Delaware) Common Stock (ATNM)
Stock · AMEX · Health Care
$1.01as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
About ATNM
Actinium Pharmaceuticals, Inc. develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies. The company offers Actimab-A, a CD33 targeting radiotherapeutic for patients with Relapsed/Refractory AML which is in to a Phase 2/3 Trial; and Iomab-ACT, to improve patient access to and outcomes with cellular therapies, such as C…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 27
- Website
- www.actiniumpharma.com
Fundamentals
- 1-day range
- $0.9351$1.09
- Market cap
- $25.46M
- P/E (trailing)
- 2.97
- P/E (forward)
- -1.98
- EPS (trailing)
- $0.35
- Dividend yield
- —
- Beta
- 0.02
- Avg. volume
- 131.3K
- Dividend pay date
- August 11, 2020
How Actinium Pharmaceuticals Inc. (Delaware) Common Stock Makes Money
Where the revenue actually goes — FY2022 annual results
Source: 10-K filed Mar 31, 2023 · via SEC EDGAR / Finnhub
Forecasts
4 analyst ratings
Actinium Pharmaceuticals Inc. (Delaware) Common Stock Competitors
Chosen by industry and closest market cap.
- ATNMActinium Pharmaceuticals Inc. (Delaware) Common Stock$1.01▲ 1.00%Market cap $25.46MP/E 2.97$0.735$1.81
- ACTUActuate Therapeutics Inc. Common stock$1.67▼ 1.18%Market cap $25.36MP/E —$0.9$9.22
- TVRDTvardi Therapeutics Inc. Common Stock$1.8▲ 0.00%Market cap $25.13MP/E —$1.5$43.65
- BTAIBioXcel Therapeutics Inc. Common Stock$0.1824▼ 74.63%Market cap $26.17MP/E —$0.1569$4.29
- BRNSBarinthus Biotherapeutics plc American Depositary Shares$0.7464▲ 2.11%Market cap $24.51MP/E —$0.512$1.83
- ABVCABVC BioPharma Inc. Common Stock$0.8251▲ 3.66%Market cap $27.62MP/E —$0.7069$3.4
- CALCCalciMedica Inc. Common Stock$0.4644▼ 1.19%Market cap $23.14MP/E —$0.4606$7.2
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| ATNM Actinium Pharmaceuticals Inc. (Delaware) Common Stock | $25.46M | 2.97 | $1.01 | ▲ 1.00% | $0.735$1.81 |
| ACTU Actuate Therapeutics Inc. Common stock | $25.36M | — | $1.67 | ▼ 1.18% | $0.9$9.22 |
| TVRD Tvardi Therapeutics Inc. Common Stock | $25.13M | — | $1.8 | ▲ 0.00% | $1.5$43.65 |
| BTAI BioXcel Therapeutics Inc. Common Stock | $26.17M | — | $0.1824 | ▼ 74.63% | $0.1569$4.29 |
| BRNS Barinthus Biotherapeutics plc American Depositary Shares | $24.51M | — | $0.7464 | ▲ 2.11% | $0.512$1.83 |
| ABVC ABVC BioPharma Inc. Common Stock | $27.62M | — | $0.8251 | ▲ 3.66% | $0.7069$3.4 |
| CALC CalciMedica Inc. Common Stock | $23.14M | — | $0.4644 | ▼ 1.19% | $0.4606$7.2 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Actinium Pharmaceuticals Advances Actimab-A Program With New Patents, Expanded Manufacturing Capacity And Clinical Milestones Into 2027Benzinga · 8/14/2026
- Actinium Pharmaceuticals Receives NYSE American Compliance Plan Acceptance, Granted Until Nov. 27, 2027 To Regain Listing ComplianceBenzinga · 8/14/2026
- Actinium Pharmaceuticals Q2 EPS $0.89 Beats $(0.21) Estimate, Sales $35.000MBenzinga · 8/12/2026
Institutional Ownership
March 31, 2026
- Total shares held
- 5.26M
- Total value held
- $4.59M
- Institutional holders
- 52
- Unknown1.26M
- Unknown600.8K
- Unknown564.6K
- Unknown471.6K
- Unknown371.2K
- Unknown337.2K
- Unknown336.1K
- Unknown201.3K
- Unknown126.2K
- Unknown124.0K
See the full, filterable feed with live charts on the MarketWall dashboard.